h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
MHHi007-A
Registration Summary
:
A
P
E
C
HSC_F1488_SeV-iPS2
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
MHHi007-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
MHHi007-A (RRID:CVCL_VN31)
Alternative name(s)
HSC_F1488_SeV-iPS2
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
16th January 2018
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Hannover Medical School (MHH)
External Databases
Cellosaurus
CVCL_VN31
Wikidata
Q95989468
General Information
Publications
Malysheva SV et al. Generation of a human CDX2 knock-in reporter iPSC line (MHHi007-A-1) to model human trophoblast differentiation. Stem cell research. 2018 Jul;30:117-121.
Halloin C et al. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture. Stem cell reports. 2019 Aug 13;13(2):366-379.
Hayder H et al. Overexpression of miR-210-3p Impairs Extravillous Trophoblast Functions Associated with Uterine Spiral Artery Remodeling. International journal of molecular sciences. 2021 Apr 12;22(8).
Shum IO et al. An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders. Cells. 2023 Aug 15;12(16).
Subclones
MHHi007-A-1
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.